The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers

被引：0
|
作者：
Bernard, Mark A. [1 ,2 ]
Boutajangout, Allal [1 ,2 ]
Debure, Ludovic [1 ,2 ]
Ahmed, Wajiha [1 ,2 ]
Briggs, Anthony Q. [1 ,2 ]
Boza-Calvo, Carolina [2 ,3 ,4 ]
Vedvyas, Alok [1 ,2 ]
Marsh, Karyn [1 ,2 ]
Bubu, Omonigho M. [1 ,2 ,5 ]
Osorio, Ricardo S. [2 ,5 ]
Wisniewski, Thomas [1 ,2 ,6 ]
Masurkar, Arjun, V [1 ,2 ,6 ]
机构：
[1] NYU, Ctr Cognit Neurol, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA
[2] NYU, Alzheimers Dis Res Ctr, Grossman Sch Med, New York, NY 10012 USA
[3] Univ Costa Rica, Ctr Invest Hematol & Trastornos Afines CIHATA, San Jose, Costa Rica
[4] Univ Costa Rica, Escuela Med, San Jose, Costa Rica
[5] NYU, Grossman Sch Med, Dept Psychiat, New York, NY USA
[6] NYU, Neurosci Inst, Grossman Sch Med, New York, NY USA
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2024年 / 102卷 / 04期
关键词：
Alzheimer's disease; anxiety; biomarkers; dementia; plasma; MILD BEHAVIORAL IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; COGNITIVE IMPAIRMENT; DEMENTIA; RISK; ASSOCIATION; COHORT;
D O I：
10.1177/13872877241295324
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Anxiety is highly prevalent in Alzheimer's disease (AD), correlating with cerebrospinal fluid/positron emission tomography biomarkers and disease progression. Relationships to plasma biomarkers are unclear. Herein, we compare levels of plasma biomarkers in research participants with and without anxiety at cognitively normal, mild cognitive impairment, and AD dementia stages. We observed significantly higher plasma tau/amyloid-beta(42) ratio in AD participants with anxiety versus those without, but did not observe differences at other stages or plasma biomarkers. No such relationships were evident with depression. These results support a unique pathophysiological relationship between anxiety and AD that can be reflected in plasma biomarkers, suggestive of heightened neurodegeneration.
引用
收藏
页码：987 / 993
页数：7
相关论文
共 50 条
  • [31] Loss of association between plasma irisin levels and cognition in Alzheimer's disease
    Kim, Keun You
    Kwak, Seyul
    Ha, Junghee
    Oh, Dae Jong
    Kim, Minae
    Cho, So Yeon
    Kim, Hyunjeong
    Lee, Jun-Young
    Kim, Eosu
    PSYCHONEUROENDOCRINOLOGY, 2022, 136
  • [32] Plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease
    Pilotto, A.
    Ashton, N. J.
    Lupini, A.
    Battaglio, B.
    Gipponi, S.
    Cottini, E.
    Grossi, I.
    Salvi, A.
    de Petro, G.
    Pizzi, M.
    Blennov, K.
    Gonzalez, M.
    Aarsland, D.
    Zetterberg, H.
    Padovani, A.
    MOVEMENT DISORDERS, 2022, 37 : S546 - S547
  • [33] The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease
    Pandya, Sneha
    Kuceyeski, Amy
    Raj, Ashish
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (04) : 1639 - 1657
  • [34] The relationship between leptin levels and cognitive status and disease stages in patients with Alzheimer's disease
    Tuncer, I.
    Yuksel, G.
    Tireli, H.
    MOVEMENT DISORDERS, 2021, 36 : S36 - S38
  • [35] The Relationship between Plasma Oxytocin Levels and Social Anxiety Symptoms
    Oh, Kang-Seob
    Kim, Eun-Jin
    Ha, Ju-Won
    Woo, Hee-Yeon
    Kwon, Min-Jung
    Shin, Dong-Won
    Shin, Young-Chul
    Lim, Se-Won
    PSYCHIATRY INVESTIGATION, 2018, 15 (11) : 1079 - 1086
  • [36] Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics
    Bluma, Marina
    Chiotis, Konstantinos
    Bucci, Marco
    Savitcheva, Irina
    Matton, Anna
    Kivipelto, Miia
    Jeromin, Andreas
    De Santis, Giovanni
    Di Molfetta, Guglielmo
    Ashton, Nicholas J.
    Blennow, Kaj
    Zetterberg, Henrik
    Nordberg, Agneta
    EBIOMEDICINE, 2025, 112
  • [37] Plasma biomarkers for Alzheimer's
    Arnaud, Celia
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (06) : 6 - 6
  • [38] Association of PTHrP levels in CSF with Alzheimer's disease biomarkers
    Kushnir, Mark M.
    Michno, Wojciech
    Rockwood, Alan L.
    Blennow, Kaj
    Strathmann, Frederick G.
    Hanrieder, Jorg
    CLINICAL MASS SPECTROMETRY, 2019, 14 : 124 - 129
  • [39] Relationship of dementia screening tests with biomarkers of Alzheimer's disease
    Galvin, James E.
    Fagan, Anne M.
    Holtzman, David M.
    Mintun, Mark A.
    Morris, John C.
    BRAIN, 2010, 133 : 3290 - 3300
  • [40] Association between BrainAGE and Alzheimer's disease biomarkers
    Abughofah, Yousaf
    Deardorff, Rachael
    Vosmeier, Aaron
    Hottle, Savannah
    Dage, Jeffrey L.
    Dempsey, Desarae
    Apostolova, Liana G.
    Brosch, Jared
    Clark, David
    Farlow, Martin
    Foroud, Tatiana
    Gao, Sujuan
    Wang, Sophia
    Zetterberg, Henrik
    Blennow, Kaj
    Saykin, Andrew J.
    Risacher, Shannon L.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2025, 17 (01)
12345